Literature DB >> 16648107

Giant splenic metastasis due to lung adenocarcinoma.

Ana Sánchez-Romero1, Israel Oliver, David Costa, Albina Orduña, Javier Lacueva, Francisco Pérez-Vicente, Antonio Arroyo, Rafael Calpena.   

Abstract

Lung cancer is the most prevalent malignancy in western countries and most of the patients present at advanced stages, but single splenic metastasis is exceptional instead. We report on a case of a seventy- three-year old male presenting with non-hemoptoic productive cough, constitutional syndrome and pain in the left lower quadrant. Physical examination and complementary radiological and histological procedures revealed the presence of an adenocarcinoma of the left lung with probable splenic metastasis. The patient underwent splenectomy, which confirmed the diagnose of splenic metastasis of lung adenocarcinoma and, secondly, lung resection was performed. Topics about lung cancer metastasis are discussed.

Entities:  

Mesh:

Year:  2006        PMID: 16648107     DOI: 10.1007/BF02664942

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  6 in total

1.  Unusual sites of malignancy: case 3. Solitary splenic metastasis in lung cancer with spontaneous rupture.

Authors:  S Massarweh; H Dhingra
Journal:  J Clin Oncol       Date:  2001-03-01       Impact factor: 44.544

2.  Patterns of metastatic cancer in the spleen.

Authors:  J H MARYMONT; S GROSS
Journal:  Am J Clin Pathol       Date:  1963-07       Impact factor: 2.493

3.  Tumors of the spleen.

Authors:  L Morgenstern; J Rosenberg; S A Geller
Journal:  World J Surg       Date:  1985-06       Impact factor: 3.352

4.  Cytokeratins and lung carcinomas.

Authors:  N V Nhung; P Mirejovský; T Mirejovský; L Melínová
Journal:  Cesk Patol       Date:  1999-07

5.  Splenic metastasis of lung cancer.

Authors:  H Satoh; K Watanabe; H Ishikawa; Y T Yamashita; M Ohtsuka; K Sekizawa
Journal:  Oncol Rep       Date:  2001 Nov-Dec       Impact factor: 3.906

6.  Isolated splenic metastasis from non small cell lung cancer.

Authors:  C S Pramesh
Journal:  Ann Thorac Cardiovasc Surg       Date:  2004-08       Impact factor: 1.520

  6 in total
  6 in total

1.  Isolated splenic metastasis from lung squamous cell carcinoma.

Authors:  Andre R Dias; Rodrigo A Pinto; Juliana N Ravanini; Renato M Lupinacci; Ivan Cecconello; Ulysses Ribeiro
Journal:  World J Surg Oncol       Date:  2012-01-27       Impact factor: 2.754

2.  Isolated spleen recurrence in a patient with lung adenocarcinoma: A case report.

Authors:  Kesato Iguchi; Osamu Ishibashi; Tadashi Kondo; Katsunori Kagohashi; Norio Takayashiki; Hiroaki Satoh
Journal:  Exp Ther Med       Date:  2015-05-27       Impact factor: 2.447

Review 3.  Splenectomy for non-haematological metastatic malignant disease.

Authors:  Piers A C Gatenby; Satvinder S Mudan; Andrew C Wotherspoon
Journal:  Langenbecks Arch Surg       Date:  2011-02-17       Impact factor: 3.445

4.  Solitary splenic metastasis from lung adenocarcinoma: A case report.

Authors:  Kantaro Hara; Nobuhiro Izumi; Takuma Tsukioka; Hiroaki Komatsu; Michihito Toda; Hikaru Miyamoto; Satoshi Suzuki; Takuya Kimura; Toshihiko Shibata; Noritoshi Nishiyama
Journal:  Thorac Cancer       Date:  2017-07-21       Impact factor: 3.500

5.  Isolated Splenic Metastasis from Non-Small-Cell Lung Cancer: A Case Report and Review of the Literature.

Authors:  Nikolaos Mitsimponas; Maria Mitsogianni; Felipe Crespo; Karl-Axel Hartmann; Stefan Diederich; Bernd Klosterhalfen; Aristoteles Giagounidis
Journal:  Case Rep Oncol       Date:  2017-07-11

6.  Isolated Splenic Metastasis of Primary Lung Cancer Presented as Metachronous Oligometastatic Disease-A Case Report.

Authors:  Milorad Reljic; Boris Tadic; Katarina Stosic; Milica Mitrovic; Nikola Grubor; Stefan Kmezic; Miljan Ceranic; Vladimir Milosavljevic
Journal:  Diagnostics (Basel)       Date:  2022-01-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.